Across TCGA pan-cancer cohorts, UBE2Q2P1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated UBE2Q2P1 data layer compared with 23 for mass-spec protein.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher UBE2Q2P1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated UBE2Q2P1 expression acts as an unfavorable survival marker.

KIRP and THCA are the cancer types where UBE2Q2P1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Median	All	0.040	0.912	<.001	36	view →
THCA	DFS	Median	All	0.087	0.896	<.001	24	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: UBE2Q2P1 tumor-vs-normal RNA expression · all UBE2Q2P1 data types